GAITHERSBURG, Md., Nov. 11, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M adjuvant, today ...

Infectious diseases remain a significant cause of morbidity and mortality in many African countries; with the resulting socio-economic consequences contributing to productivity losses and hence slowed ...

The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 578 million (USD 4.0 million1) in four projects for the development of new diagnostics and ...

Antibody proteomics advances vaccine research, revealing immune responses and identifying proteins essential for developing effective vaccines against diseases.

The continent is being drenched in an avalanche of medical disinformation with the aim of undermining western influence ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.

Maternal antibodies passed across the placenta can interfere with the response to the malaria vaccine, which would explain its lower efficacy in infants under five months of age, according to research ...

Adar Poonawalla, CEO of Serum Institute of India and Chairman of Poonawalla Fincorp, has recently acquired a 50% stake in Karan Johar’s Dharma Productions. Known for his leadership in vaccine ...

Chad today kicked off an ambitious triple vaccine rollout, including the R21 malaria vaccine, marking a significant step forward in its efforts to safeguard the health and well-being of millions of ...